659 related articles for article (PubMed ID: 6284625)
1. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
Chen DS; Sung JL; Lai MY
Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
[TBL] [Abstract][Full Text] [Related]
2. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
Theodoropoulos G; Nakopoulou L; Fertakis A; Papaevangelou G; Hadzis G; Kasfiki A
Hepatogastroenterology; 1983 Dec; 30(6):243-5. PubMed ID: 6327477
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
4. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
[TBL] [Abstract][Full Text] [Related]
5. [e/Anti-e system in liver disease].
Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
[TBL] [Abstract][Full Text] [Related]
6. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
8. [Radioimmunological determination of HBeAg/anti-HBe in HBsAg-positive liver diseases and in "healthy" HBsAg carriers].
Arnold W; Hess G; Dormeyer HH; Gahl G; Hoffmann HG; Knolle J; Schönborn H
Z Gastroenterol; 1979 Oct; 17(10):704-12. PubMed ID: 118595
[TBL] [Abstract][Full Text] [Related]
9. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
[TBL] [Abstract][Full Text] [Related]
10. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A
Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
[TBL] [Abstract][Full Text] [Related]
11. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
[No Abstract] [Full Text] [Related]
12. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
Jelić D; Jelić O
Acta Med Croatica; 1994; 48(2):77-83. PubMed ID: 7519502
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis B virus DNA detection by means of polymerase chain reaction in patients with chronic hepatitis and hepatocellular carcinoma].
Song Y; Pan W; Fan Z; Du P; Qi Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):220-2. PubMed ID: 15617333
[TBL] [Abstract][Full Text] [Related]
15. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
Chang MH; Hsu HY; Hsu HC; Ni YH; Chen JS; Chen DS
Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HBe-Ag and anti-HBe in asymptomatic HBs-Ag carriers and patients with liver disease.
Shanmugam J; Balakrishnan V; Thomas M; Jayaprakash PA
Indian J Pathol Microbiol; 1983 Jan; 26(1):1-5. PubMed ID: 6315579
[No Abstract] [Full Text] [Related]
17. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
[TBL] [Abstract][Full Text] [Related]
18. [The presence and significance of HBe antigens and anti-HBe antibodies in HBs antigen positive patients].
Zivanović-Marinković V; Kaljalović R; Marinković V; Dumović B; Lazarov A; Nanusević N; Krstić L; Parabucki S
Zb Vojnomed Akad; 1981; 23():24-6. PubMed ID: 6963836
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
